Groupe Actiplay SA Stock Company Profile
Information
Bâtiment Inserm U1148, Hôpital Bichat Secteur Claude Bernard 46, rue Henri Huchard
Paris 75877
33 9 70 46 86 40
acticor-biotech.com
Industry: Biotechnology
Sector: Healthcare
Description
Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.
